181 related articles for article (PubMed ID: 21765928)
1. Solution structure of tensin2 SH2 domain and its phosphotyrosine-independent interaction with DLC-1.
Dai K; Liao S; Zhang J; Zhang X; Tu X
PLoS One; 2011; 6(7):e21965. PubMed ID: 21765928
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
Chen L; Liu C; Ko FC; Xu N; Ng IO; Yam JW; Zhu G
J Biol Chem; 2012 Jul; 287(31):26104-14. PubMed ID: 22645138
[TBL] [Abstract][Full Text] [Related]
3. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
Hafizi S; Sernstad E; Swinny JD; Gomez MF; Dahlbäck B
Int J Biochem Cell Biol; 2010 Jan; 42(1):52-61. PubMed ID: 19747564
[TBL] [Abstract][Full Text] [Related]
4. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
Liao YC; Si L; deVere White RW; Lo SH
J Cell Biol; 2007 Jan; 176(1):43-9. PubMed ID: 17190795
[TBL] [Abstract][Full Text] [Related]
5. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
Chan LK; Ko FC; Ng IO; Yam JW
PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
[TBL] [Abstract][Full Text] [Related]
6. 1H, 15N and 13C chemical shift assignments of the SH2 domain of human tensin2 (TENC1).
Chen L; Liu C; Rui F; Zhu G
Biomol NMR Assign; 2011 Oct; 5(2):211-4. PubMed ID: 21461930
[TBL] [Abstract][Full Text] [Related]
7. Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.
Chen H; Duncan IC; Bozorgchami H; Lo SH
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):733-8. PubMed ID: 11792844
[TBL] [Abstract][Full Text] [Related]
8. Cellular phosphatase activity of C1-Ten/Tensin2 is controlled by Phosphatidylinositol-3,4,5-triphosphate binding through the C1-Ten/Tensin2 SH2 domain.
Kim E; Kim DH; Singaram I; Jeong H; Koh A; Lee J; Cho W; Ryu SH
Cell Signal; 2018 Nov; 51():130-138. PubMed ID: 30092354
[TBL] [Abstract][Full Text] [Related]
9. The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.
Moon KD; Zhang X; Zhou Q; Geahlen RL
Biochim Biophys Acta; 2012 Feb; 1823(2):199-205. PubMed ID: 22019427
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
[TBL] [Abstract][Full Text] [Related]
11. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.
Zhang Y; Wavreille AS; Kunys AR; Pei D
Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650
[TBL] [Abstract][Full Text] [Related]
12. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
13. Tensin.
Lo SH
Int J Biochem Cell Biol; 2004 Jan; 36(1):31-4. PubMed ID: 14592531
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.
Wang Z; Nie Y; Zhang K; Xu H; Ramelot TA; Kennedy MA; Liu M; Zhu J; Yang Y
Arch Biochem Biophys; 2018 Oct; 656():31-37. PubMed ID: 30165040
[TBL] [Abstract][Full Text] [Related]
16. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous binding of two peptidyl ligands by a SRC homology 2 domain.
Zhang Y; Zhang J; Yuan C; Hard RL; Park IH; Li C; Bell C; Pei D
Biochemistry; 2011 Sep; 50(35):7637-46. PubMed ID: 21800896
[TBL] [Abstract][Full Text] [Related]
18. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2.
Kawai K; Kitamura SY; Maehira K; Seike J; Yagisawa H
Adv Enzyme Regul; 2010; 50(1):202-15. PubMed ID: 19895840
[No Abstract] [Full Text] [Related]
19. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains.
Woodside DG; Obergfell A; Talapatra A; Calderwood DA; Shattil SJ; Ginsberg MH
J Biol Chem; 2002 Oct; 277(42):39401-8. PubMed ID: 12171941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]